Cases & Deals

Funds managed by Invesco Asset Management Limited invest in Mereo BioPharma Group

Clients Invesco Asset Management Limited

Jones Day advised Invesco Asset Management managed funds on their investment alongside Woodford Investment Management in the $119 million (c. £76.5 million) capital raise by Mereo BioPharma Group Ltd. Novartis Pharmaceuticals, through shares issued in consideration for the acquisition of clinical-stage development programs, will also hold an equity stake in Mereo.

Mereo is a recently-formed specialty biopharmaceutical company focused on developing innovative medicines, particularly in rare and specialist disease areas, through the acquisition of validated, mid-stage development programs from large biopharmaceutical or biotechnology companies.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.